Showing results (151-160 of 185) with videos related to
Sort By:
Pageof 19
Nitric Oxide : Biology and Chemistry|December 19, 2012
Contribution of either YY1 or BclXL-induced inhibition by the NO-donor DETANONOate in the reversal of drug resistance, both in vitro and in vivo. YY1 and BclXL are overexpressed in prostate cancerSara Huerta-Yepez, Stavroula Baritaki, Guillermina Baay-Guzman, et al.International Journal of Oncology|September 24, 2015
Overcoming rituximab drug-resistance by the genetically engineered anti-CD20-hIFN-α fusion protein: Direct cytotoxicity and synergy with chemotherapyGabriel G Vega, Luz Areli Franco-Cea, Sara Huerta-Yepez, et al.Cancer Investigation|February 25, 2009
YY1 Over-expression in human brain gliomas and meningiomas correlates with TGF-beta1, IGF-1 and FGF-2 mRNA levelsStavroula Baritaki, Anthoula M Chatzinikola, Antonios F Vakis, et al.Cell Cycle (Georgetown, Tex.)|August 9, 2011
Mcl-1 and YY1 inhibition and induction of DR5 by the BH3-mimetic Obatoclax (GX15-070) contribute in the sensitization of B-NHL cells to TRAIL apoptosisMelisa A Martínez-Paniagua, Stavroula Baritaki, Sara Huerta-Yepez, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 10, 2011
An antibody-based multifaceted approach targeting the human transferrin receptor for the treatment of B-cell malignanciesTracy R Daniels, Elizabeth Ortiz-Sánchez, Rosendo Luria-Pérez, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 2, 2004
Downregulation of Smac/DIABLO expression in renal cell carcinoma and its prognostic significanceYoichi Mizutani, Hiroyuki Nakanishi, Kosuke Yamamoto, et al.British Journal of Haematology|December 5, 2009
The proteasome inhibitor CEP-18770 enhances the anti-myeloma activity of bortezomib and melphalanEric Sanchez, Mingjie Li, Jeffrey A Steinberg, et al.The Journal of Surgical Research|July 3, 2007
Modification of gene products involved in resistance to apoptosis in metastatic colon cancer cells: roles of Fas, Apaf-1, NFkappaB, IAPs, Smac/DIABLO, and AIFSergio Huerta, John H Heinzerling, Yu-Mei Anguiano-Hernandez, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 20, 2007
Expression of X-linked inhibitor of apoptosis protein is a strong predictor of human prostate cancer recurrenceDavid B Seligson, Fumiya Hongo, Sara Huerta-Yepez, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 10, 2004
Chemokine monokine induced by IFN-gamma/CXC chemokine ligand 9 stimulates T lymphocyte proliferation and effector cytokine productionDavid Whiting, George Hsieh, James J Yun, et al.Pageof 19